ARCHIVES

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

This article is from The Cancer Letter archive.

Vol. 01 No. 09 | April 5, 1974

Download PDF Visit The Full Archive

Related Articles

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

Cooperative Group Trials Approved By NCI Are Listed

August 26, 2005

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

AACR Selects Eight Finalists To Compete For $15 Million Grants Funded By Telethon.

December 5, 2008

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009

Scientist’s Interpretation Of Meta-Analysis On ESAs Turns 180 Degrees Over 72 Hours.

June 8, 2007